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The objective of this article is to review and summarize the extant literature on head and neck cancer (HNC) patients’
informational needs and to characterize emerging issues in this patient population in order to define priorities for future
research. HNC patients may undergo challenging treatment regimens and experience treatment-related alterations in
primary daily functions such as speech and eating. These changes often persist following treatment and may lead to
significant deficits in quality of life and interpersonal relations. Despite empirical evidence demonstrating that receipt of
adequate information and support is predictive of improved outcomes post-treatment, relatively limited attention has
been paid to the informational and support needs of HNC patients. This review focuses primarily on three topic domains:
(1) managing treatment-related side effects; (2) addressing alcohol and tobacco dependence; and (3) informational needs
in the areas of human papillomavirus (HPV) and clinical trials. While there is increasing awareness of the rehabilitation and
survivorship needs in this patient population, patients note that the impact of treatment on social activities and
interactions is under-discussed and of key concern. In addition, there is a significant gap in addressing communication
and informational needs of caregivers and family members who are integral for promoting healthy behaviors and self-care
post-treatment. Greater integration of programs that address tobacco or alcohol dependency within a comprehensive
treatment and support plan may increase patient motivation to seek help and enhance patient success in maintaining
long-term abstinence. Finally, emerging patient-provider communication needs, particularly in the context of decision
making about clinical trials or surrounding an HPV-related diagnosis, have been noted among both patients and
healthcare providers. Future research on the development of novel programs that offer feasible and acceptable
methods for addressing unmet informational and support needs is warranted and may yield benefit for improving
patient-reported outcomes.
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Despite advances in diagnostic tools and treatment
modalities, treatment for head and neck squamous cell
carcinoma (HNC) can lead to considerable long-term
functional impairment. Patients may experience diffi-
culty swallowing, dry mouth, nutritional deficits, pain,
and declines in social functioning, speech, and sexual-
ity [1]. Physical and psychosocial complaints can
persist even following successful therapy [2], and
patients often report significant decrements in quality* Correspondence: carolyn.fang@fccc.edu
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increased social isolation [3].
Notably, empirical data indicate that patients’ percep-
tions of having obtained adequate information and
support are predictive of positive rehabilitation out-
comes in the 2- to 6-year post-treatment period [4].
However, despite the complexity of treatment regimens
and challenging recovery process, relatively limited at-
tention has been paid to the informational and support
needs of HNC patients. Therefore, the objective of this
article is to briefly review and summarize the extant lit-
erature on informational and support needs and to
characterize emerging issues in this patient population
to help define priorities for future research.le is distributed under the terms of the Creative Commons Attribution 4.0
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Symptom management and treatment side effects
HNC patients undergoing surgical treatment may
experience physical alterations on a part of their body
that is highly visible (i.e. face) and with significant impli-
cations for social interactions. As a result, several studies
focused on issues of postoperative changes in appear-
ance or speech [5–7]. In a cross-sectional study of 280
surgical patients who were surveyed regarding body
image [5], 75 % reported feeling concerned or embar-
rassed by bodily changes related to the cancer and/or its
treatment at some point following diagnosis. The con-
cerns most commonly expressed by patients involved
scarring and disfigurement (42.3 %), speaking-related is-
sues (35.8 %), loss of teeth (30.1 %), and social eating
(25.1 %) [5]. Other concerns included swelling, drooling,
hair loss, and weight loss. And despite patients’ overall
levels of satisfaction with their healthcare team, a sub-
group of patients had unmet informational needs. Specif-
ically, 25 % of patients reported dissatisfaction with the
information received about the degree of scarring/disfig-
urement to be expected following surgery; 32 % were
dissatisfied with information received about the potential
effects of radiation treatment on physical appearance, and
44 % reported dissatisfaction with information about
potential effects of chemotherapy on physical appearance.
Factors associated with dissatisfaction included age and
time since diagnosis, with younger patients reporting
higher levels of dissatisfaction and body image concerns.
Levels of dissatisfaction were also found to increase after
surgery and remain elevated one-year post-surgery. Over-
all, more than one-third of patients reported that greater
informational resources to help manage multiple concerns
would have been helpful [5].
Among surgical patients, a desire for greater pre-
operative education and preparation for post-operative
changes has been reported [8], particularly in the
domains of speech [9] and eating [8, 10]. In an early
study, questionnaires assessing informational needs and
support services were completed by 125 patients who
had undergone laryngectomy for treatment of their can-
cer and 28 spouses. Among patients, 21 % were not sat-
isfied with the information received prior to surgery and
were unaware preoperatively of the inability to speak
after surgery [9]. Importantly, 61 % of patients and 81 %
of spouses reported that the information provided was
insufficient [9]. A smaller study evaluated informational
needs and eating-related experiences among 34 patients
who were recruited from an Internet-based laryngec-
tomy support group. Similar to prior findings, most
patients reported dissatisfaction with the information
received, particularly with regard to the effects of laryn-
gectomy on loss of taste and changes in eating [10]. Im-
portantly, the majority of patients and spouses desired tohave a conversation about how treatment may impact
social activities and interactions with friends, family
members, and other individuals in a public setting [8].
Of note, studies have revealed a potential disconnect
between what doctors believe their patients are worried
about and what patients say they are worried about.
Healthcare professionals perceived that speech impair-
ment and self-image were patients’ primary concerns
after surgery; however, patients rated concerns about the
physical consequences of treatment and its interference
with social activities as key concerns post-surgery [11].
Alterations in the social nature of eating are frequently
reported by patients as topics that deserve more atten-
tion [8, 10]. In addition, patients desire more informa-
tion on nutrition and strategies for coping with loss of
smell or taste [10]. In the absence of receiving appropriate
referrals to nutritionists or other support professionals,
patients often turn to internet Web sites or support
groups to seek the information they desire [10, 12], al-
though the information obtained from these sources may
not be reliable or accurate. While healthcare professionals
may wish to avoid burdening the patient with detailed
nutrition and dietary recommendations during the early
stage of rehabilitation, patients do not perceive advice
to “just eat something” to be particularly helpful [10],
further underscoring the disconnect between patients
and their providers.
In addition to swallowing and speech issues, there is
growing awareness that HNC patients experience sleep
disturbance. Among 58 HNC patients who completed a
cross-sectional survey on sleep and fatigue, greater sleep
dysfunction was associated with younger age and higher
symptom burden [13]. Multiple factors may contribute to
sleep dysfunction and poor sleep quality, as observed in a
longitudinal, prospective study of 457 HNC patients in
which pain, xerostomia, depression, presence of a trache-
otomy tube, and younger age were significant predictors
of poor sleep quality one-year post-diagnosis [14]. How-
ever, treatment type (surgery, radiation, or chemotherapy),
primary tumor site, and cancer stage were not significantly
associated with sleep quality over time.
Sleep disruption may be due to not only pain or symp-
tom burden, but also the physiologic alterations result-
ing from the tumor or cancer treatment. Both radiation
and surgical treatments lead to changes in the upper
airway that can contribute to the development of ob-
structive sleep apnea (OSA) [15]. Although there have
been few studies of OSA in HNC patients, the limited
data available suggest that HNC patients are at increased
risk of OSA [16–19]. One study of 17 HNC patients
who were assessed prior to surgical treatment revealed
the presence of OSA in 13 patients (76 %) [18]. A retro-
spective review of 56 HNC patients who had also under-
gone formal sleep evaluation found that patients with
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were more likely to have OSA [20]. And in contrast to
the general population, where obesity is a risk factor for
the development of OSA, HNC patients with OSA are
not more likely to be obese or overweight [15, 20, 21],
suggesting that anatomic changes resulting from the
tumor or cancer treatment may predispose patients to
the development of OSA. Because many symptoms of
OSA are nonspecific (daytime sleepiness, insomnia, dry
mouth upon awakening) and could be attributed to
other factors, patients may be unaware that they are
suffering from a potentially treatable sleep disorder [22].
Clinicians and healthcare providers can help patients
identify symptoms of OSA and provide referrals to sleep
specialists if warranted.
Other unmet informational and support needs that
have been identified pertain to financial and psychosocial
domains. In a prospective study of 82 newly diagnosed
HNC patients, informational needs commonly reported
at pre-treatment included issues involving financial
support (78 %), access to support groups for patient or
partner (52 %), treatment side effects (50 %), and how
treatment may impact QOL and functioning over the
next year (43 %) [23]. Patients were hetereogenous with
respect to treatments received (surgery only, radiation
only, or a combination of surgery, radiation, and chemo-
therapy) and were re-assessed 1 month post-treatment,
at which time 60 % of patients continued to report that
they had not received any information regarding finan-
cial support, 34 % had not received information about
support groups, and 28 % had not received information
about treatment side effects or how treatment may
impact functioning over time [23]. In light of the fact
that study respondents had access to healthcare and
were recruited from research hospital settings (which
may have more resources to offer patients), it is possible
that these data are underestimates of financial and other
concerns than what might be found in the broader HNC
patient population. To date, the informational and sup-
port needs of HNC patients who are uninsured, lack
access to healthcare, or are being managed in commu-
nity practices or other settings is not well-characterized.
Family caregivers often play an important role in sup-
porting HNC patients and providing assistance during
and after treatment [24, 25]. Similar to patients, care-
givers of HNC patients report many unmet informa-
tional needs [24, 26]. Among 59 family caregivers of
HNC patients who had completed radiation therapy,
nearly 75 % reported high informational needs at diag-
nosis [24]. Although caregivers’ needs decreased over
time, over half of caregivers still had high informational
needs at the end of treatment. Predominant concerns
included reducing patient pain and distress across the
treatment trajectory. Similarly, in a qualitative study oforal cancer patients and their family caregivers, care-
givers requested more information on pain management
and self-care [26]. Finally, both patients and caregivers
desired more information regarding managing side ef-
fects and nutrition issues [26].
The extant literature has characterized patients’ unmet
informational and support needs across multiple domains,
but limitations of the existing research include small sam-
ple sizes in many studies, wide variability in the timing of
study assessments relative to treatment and across studies,
and a reliance on predominantly cross-sectional study
designs. Most studies utilized a convenience sample com-
prised of predominantly non-Hispanic whites, and there-
fore informational and support needs of HNC patients
from other racial/ethnic subgroups are not well-described.
In addition, the studies conducted have tended to use
varied measures to assess informational needs and satis-
faction with information received, thereby making it diffi-
cult to compare across studies. However, a standardized
measure of satisfaction with information has been devel-
oped and evaluated specifically among HNC patients [27].
This measure, the Satisfaction with Cancer Information
Profile (SCIP), assesses patient satisfaction with the
amount and content of information, as well as the form
and timing of the information received [27]. The use of
standardized and validated measures will help promote
greater consistency in the assessment and identification of
informational needs over time across diverse HNC patient
subgroups.
Multimedia interventions can offer a promising
approach to addressing communication and information
needs. In one study, partners of HNC patients received a
multimedia-based program including a patient booklet,
interactive computer booth and take-home DVD, which
was delivered by a nurse practitioner [28]. Partners of
HNC patients who received the intervention reported
higher levels of satisfaction with the information pro-
vided compared to control group participants; import-
antly, intervention participants had lower levels of
anxiety and depression at 3–6 months [28]. Other
Internet-based programs that deliver content and fea-
tures tailored to one’s role (cancer survivor or caregiver)
have been found to be well-received by oral cancer
survivors and their family caregivers; and they offer the
potential added ability to use online tools for communi-
cating with other survivors and caregivers [26].
Due to the diversity of individual needs and preferences,
tailored communication materials may represent the best
strategy for addressing informational gaps [29, 30]. As
might be expected, younger HNC patients (29–49 years of
age) were more likely to report having Internet access
compared to older patients (65+ years), and data suggest
varied preferences regarding the format in which informa-
tion is delivered [12], with some patients preferring to
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specialist [30], whereas others are receptive to Internet-
based programs [26]. Higher education level and female
gender were also associated with greater preference for
Internet-based programs [12]. Finally, patient financial
concerns and access to healthcare services remain a
significant area of informational need that is not well-
addressed and one that warrants greater attention. In view
of the complexity of treatment-related side effects and the
extensive rehabilitation that may need to occur both dur-
ing and post-treatment, strategies to address patients’ in-
formational and support needs across the continuum of
care (from pre-treatment through post-treatment) are crit-
ically needed.
Alcohol and tobacco dependence
Following a cancer diagnosis and/or treatment, patients
may seek to maintain or improve their health via alter-
ations in lifestyle behaviors such as physical activity, diet,
smoking, or alcohol use. Given that cancer treatment
and subsequent side effects can adversely affect physical
functioning and nutritional status, numerous studies
have focused on the effects of physical activity or nutri-
tional support interventions on patient outcomes (please
see comprehensive reviews on physical activity [31–33]
and nutrition [34–36] in HNC patients). In contrast,
there have been relatively fewer studies designed to ad-
dress alcohol or tobacco dependency for those patients
with addiction disorders. Empirical data suggest that
alcohol abuse and untreated alcohol withdrawal syn-
drome can lead to treatment complications and poorer
outcomes, including failure of extubation or ventilator
weaning and higher rates of mortality [37, 38]; however,
there has been limited research focused on delivering
specialized services to treat comorbid alcoholism among
HNC patients [39, 40]. One US study published in 2010
found that 44.5 % of HNC survivors reported current
alcohol use 1 year after diagnosis [41]. Several studies
have reported various factors to be associated with on-
going alcohol use after diagnosis including: male gender,
early-stage disease, longer time since treatment, receiv-
ing chemotherapy and/or radiation therapy compared to
surgery, and superior oral functioning [41–43]. A 2016
Spanish study reported that alcohol use decreased by
16.7 % after diagnosis, and that receiving a surgeon’s
recommendation about alcohol was strongly associated
with alcohol reduction or cessation [44]. Only one ran-
domized controlled trial published in 2006 by Duffy and
colleagues tested an alcohol intervention for HNC
patients. Patients with HNC and tobacco, alcohol, or
depression disorders, about half of whom were veterans,
were randomized to a nurse-administered cognitive-
behavioral and pharmacotherapy intervention for treat-
ment of tobacco, alcohol, and depression [39]. Nosignificant differences in 6-month alcohol consumption
were observed between the intervention condition and
usual care [39], attesting to the challenges of addressing
alcohol disorders in this patient population.
There is a relatively larger body of research on tobacco-
related complications. Continued smoking after the diagno-
sis of HNC impacts treatment and risk for complications,
increases the likelihood of recurrence and second primary
cancers, and adversely affects QOL and survival [45–48].
According to a 2015 systematic review of six studies, the
survival rate for HNC patients who continued smoking
after diagnosis was 21–35 % lower than patients who quit,
and the recurrence rate for active smokers was 23–30 %
higher than for quitters [47]. In a matched-pair study of
HNC and nicotine-dependent patients published in 2007,
HNC patients who stopped using tobacco also had lower
rates of tobacco-related second primary tumors [46].
HNC patients, like other smokers, demonstrate am-
bivalence about quitting, and smoking rates among
HNC patients have remained relatively constant over the
last two decades despite the availability of an increased
number of empirically-based pharmacotherapy and be-
havioral interventions to treat tobacco dependence [49].
Many HNC patients who are smokers are interested in
quitting, and may even succeed in quitting unassisted, at
least initially. However, a significant minority of smokers
are unable to quit even after diagnosis of a smoking-
related cancer, and initial quitters are at high risk for re-
lapse. Only Duffy and colleagues’ randomized controlled
trial published in 2006 found a significant treatment effect
of a nurse-delivered cognitive-behavioral and pharmaco-
therapy tobacco cessation intervention compared to usual
care for HNC patients [39].
Despite the fact that evidence-based tobacco cessation
interventions are available, they are woefully underuti-
lized and have been minimally evaluated among HNC
patients. Providers have not fully implemented the
Public Health Service 5A guidelines for tobacco cessa-
tion (ask, advise, assess, assist, arrange) [50] among
patients with tobacco-related cancers – this is likely due
to a multitude of barriers that include patient factors
(e.g., low motivation, self-efficacy, knowledge), provider
factors (e.g., limited training, self-efficacy, time), and
system factors (e.g., high cost, minimal insurance cover-
age). Two studies of lung and HNC patients combined
demonstrated partial implementation of the 5A’s, as
assessed by self report and medical chart review, with
93 % of patients reporting that they were asked about
tobacco use, 76–86 % advised about tobacco use, 46 %
assessed for their interest in quitting, 40–65 % assisted,
but only 4 % arranged with follow-up [49, 51]. A study
published in 2011 found that individualized cessation
programs were preferred by patients, and younger
patients with early stage disease and those with partners
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[25]. A 2012 study found that delivery of 5A’s was most
likely to occur when patients requested cessation advice
from their providers. However, according to a small
qualitative study conducted at a large NCI-designated
comprehensive cancer center in the Southeast published
in 2009, patients do not ask providers for help quitting
or maintaining abstinence, and relapsed patients are
hesitant to disclose smoking due to feelings of stigma
and guilt [28]. In addition, clinicians vary in the types of
assistance they provide and their awareness and sensi-
tivity to relapsed patients' concerns [28]. The advice
and type of assistance offered by providers may not
resonate with patients—specifically, providers reported
emphasizing the long-term risks of continued smok-
ing in their interactions with patients, but lung and
HNC patients expressed a preference for a balance
between risks of smoking and benefits of quitting/ab-
stinence [52].
Few empirically-supported programs targeted for or
tested specifically with HNC patients exist. The results of
three randomized trials for HNC patients have been
published. In the first study published in 1993, the inter-
vention consisted of surgeon- or dentist-delivered advice
to stop smoking, a contracted quit date, tailored written
materials, and booster advice sessions compared to a usual
care advice control condition [53]. At randomization,
88 % were current smokers. At 12-month follow-up, 70 %
of participants completing the trial were continuous
abstainers; among baseline smokers alone, the continuous
abstinence rate was 65 %. However, the intervention effect
was not statistically significant. Predictors of continuous
abstinence were surgery rather than radiation only, greater
stage of change, younger age, lower nicotine dependence,
and race/ethnicity other than white, non-Hispanic. Based
on these findings, the authors recommended systematic
brief advice to stop smoking for HNC patients, with a
stepped-care approach for patients less able to quit [53].
In Duffy and colleagues’ study published in 2006,
Veterans Affairs Medical Center (VAMC) patients with
HNC and tobacco, alcohol, or depression disorders were
randomized to a nurse-administered cognitive-behavioral
and pharmacotherapy intervention for treatment of to-
bacco, alcohol, and depression [39]. Significant differences
in 6-month smoking cessation rates were found with 47 %
quitting in the intervention condition compared to 31 %
in the usual care condition [39]. However, a recent ran-
domized study of VAMC HNC patients published in 2016
found that receiving a $150 monetary incentive at each
test visit (1, 3, and 6 months) for being biochemically-
confirmed abstinent based on urine cotinine testing – in
addition to being paid $50 to attend each of three cessa-
tion classes provided by the VAMC – did not result in
improved cessation rates [54].Despite the mixed results that have been reported to
date, it is imperative that providers take advantage of the
“teachable moment” of a diagnosis of HNC to advise
smokers to quit, which can be quite effective [50].
Tobacco use and cessation should be addressed on an
ongoing basis with patients throughout treatment and
survivorship, including among recent quitters in order
to prevent relapse. Too often, a sporadic “Band-Aid” ap-
proach is used for tobacco cessation, even among cancer
patients, despite calls for nicotine dependence to be
managed as a chronic disease [55, 56]. In 2015, the
National Comprehensive Cancer Network published
guidelines for tobacco cessation intervention among
cancer patients [57], but the successful implementation
of these guidelines remains to be evaluated.
Emerging issues
Human papillomavirus
A topic not commonly addressed is the impact of cancer
and its treatment on sexual functioning [1, 58, 59]. In an
early study, HNC patients who had extensive facial dis-
figurement following surgical treatment reported worse
relations with their partners, increased social isolation,
and reduced sexuality compared to patients with minor
disfigurement [6]. Due to significant improvements in
facial reconstruction techniques, extensive disfigurement
is now less common; but sexual functioning may still be
impacted due to treatment-related effects on breathing,
swallowing, and speaking. Alterations in any of these
functions can have a negative impact upon intimacy,
communication, or other sexual activities. Indeed,
although 85 % of HNC patients reported moderate-to-
high interest in sexual relations, a majority (58 %) reported
arousal problems, and 58 % did not engage in sexual inter-
course [59]. Further, 51 % considered the quality of their
current sexual functioning to be poor, with younger pa-
tients (<65 years) reporting significantly poorer sexual
functioning than patients aged 65 or older [59].
In addition, data suggest that the incidence of human
papillomavirus (HPV)-associated head and neck cancers is
increasing [60–62]. Accumulating evidence point to HPV
as a causal factor in the etiology of head and neck cancers
that arise among non-smokers and non-drinkers [63, 64].
This emerging subgroup of HNC patients has specific in-
formational needs, and many clinicians find themselves
ill-prepared for these discussions. Patients may have ques-
tions about HPV-related disease that are difficult to
answer due to limited data or physician discomfort with
discussing matters related to sexual health [65].
Among HNC patients receiving an HPV-related diag-
nosis, informational and psychosocial needs are particu-
larly apparent. In a qualitative study of 10 men with
HPV-related HNC, the majority (8/10) sought additional
HPV-specific information, mostly from the Internet [66].
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many had questions regarding transmission of HPV
infection and potential consequences for current or
future partners [66]. Among 62 HNC patients who had
a long-term partner, only two-thirds of patients correctly
reported that they had an HPV+ tumor [67]; the remain-
der of patients were unsure or reported that they did not
have an HPV+ tumor. Only a minority of patients (35 %)
reported that their cancer was caused by HPV [67]. The
majority of patients reported being uninformed about
what precautions (if any) needed to be taken to prevent
HPV transmission to their partner, and 39 % reported
that their oncologist did not discuss issues related to
HPV with them. Over half (58 %) reported seeking add-
itional information from sources other than their on-
cologist [67].
The sexually-transmitted nature of HPV may create
challenges for healthcare professionals who have limited
experience discussing sexual health with their patients.
In a qualitative study of 15 healthcare professionals who
treat patients with oropharyngeal cancers, providers
described two primary challenges: (1) discomfort or lack
of familiarity with talking about sexual health and behav-
iors; and (2) limitations of scientific knowledge about
the virus [68]. Patients may desire answers to specific
questions about how they became infected with HPV,
when they became infected, who the infection was trans-
mitted from, and the likelihood of re-infection after can-
cer treatment – questions that are difficult to answer
[68]. These data highlight significant challenges and gaps
in patient-provider communication with respect to
HPV-related issues and point to the need for additional
research in this area. At present, existing data on the in-
formational needs of patients with HPV-related cancers
are quite limited as the few studies that have been con-
ducted are based on relatively small samples of patients
and physicians recruited from large academic research
institutions, which may not be representative of the
broader patient and healthcare provider population. As a
result, little is known about the informational and
support needs of patients being managed in community
practices and their community providers. Studies de-
signed to foster the development of valid and compre-
hensive educational and support programs to address
HPV-related issues would be extremely beneficial for
both patients and their providers.
Decision making about clinical trials
Another area of emerging need is the provision of infor-
mational support for clinical trials. While clinical trials are
essential to the evaluation of new therapeutic regimens, a
relatively small proportion of cancer patients participate
in these trials [69]. This is likewise true for clinical trials
specifically recruiting HNC patients, where it wasreported that over 25 % of HNC trials that had been ter-
minated, suspended, or withdrawn was due to insufficient
accrual of patients [70]. Two studies investigating barriers
to recruitment of HNC patients were identified. In one
study, 85 healthcare professionals involved in clinical trial
research (investigators, research nurses) completed a web-
based survey on barriers to clinical trial recruitment. The
most commonly reported barriers to recruitment (identi-
fied by more than 50 % of respondents) included patient
refusal to consent due to treatment preference or aversion
to randomization, the complexity and amount of informa-
tion that needs to be provided to patients, and lack of time
to support research [71], which is consistent with studies
in other cancer patient populations [72]. Further exacer-
bating this situation is the complexity of the information
that needs to be accurately conveyed, which can be
particularly challenging for patients with limited health lit-
eracy [73].
Hence, the utilization of decision aids to assist with
informed decision making about clinical trial participa-
tion has been explored as a potentially useful tool to
help patients identify their values and goals, consistent
with making an informed choice. To date, there have
been no decision aids developed to specifically support
HNC patients’ informational needs and decision making
about clinical trials. But prospective, randomized studies
involving mixed cancer patient populations have yielded
promising results. For example, among 1255 cancer pa-
tients who were randomly assigned to receive either a
web-based program that provided tailored, interactive
educational content about clinical trials (intervention
condition) or general written information about clinical
trials (control condition), intervention participants
reported significantly greater increases in knowledge and
greater decreases in attitudinal barriers compared to
control participants [74]. Thus, tailored educational pro-
grams can effectively deliver key information about clin-
ical trials and may help enhance communication about
and preparation for decision making about clinical trials.
Future research is needed to evaluate whether similar
programs yield comparable benefits in addressing HNC
patients’ informational needs and reducing barriers to
clinical trials.
Conclusion
Across studies, many patients desire additional informa-
tion and support, particularly with respect to managing
treatment-related side effects, maintaining one’s health
and healthy lifestyle behaviors after treatment, and un-
derstanding an HPV-related diagnosis. Despite the grow-
ing body of research on rehabilitation and survivorship
needs in this patient population, patients note that the
impact of treatment on social activities and interactions
is under-discussed and of key concern. Interventions
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review see [75]) often neglect to address the psycho-
logical and/or social aspects of eating and drinking, is-
sues reported to be of high importance among survivors
and which can contribute to decrements in emotional
and social well-being. In addition, there is a significant
gap in addressing communication and informational
needs of caregivers and family members who provide
considerable levels of support to the patient and are in-
tegral for promoting healthy behaviors and self-care dur-
ing and after treatment. As caregivers often express
different concerns than patients do, future studies that
address caregivers’ specific needs are warranted.
In addition, there is a need for more fully integrated
programs to provide support for managing substance
dependency issues. For example, many HNC patients ex-
press interest in quitting smoking and attempt to quit,
but fewer follow through with enrolling in evidence-
based smoking cessation programs or are successful in
maintaining long-term abstinence. Motivational inter-
ventions to facilitate enrollment into formal programs
that address alcohol or tobacco dependence among can-
cer patients may be beneficial [76]. Studies suggest that
a cancer diagnosis and subsequent treatment window of-
fers a “teachable moment” during which patients may be
motivated to initiate and maintain healthy behaviors, in-
cluding smoking cessation and decreased alcohol use
[77]. Ultimately, programs addressing tobacco or alcohol
dependency that are incorporated into a comprehensive
treatment plan may decrease the stigma associated with
substance abuse and increase patient motivation to seek
help and support for staying healthy after treatment.
Finally, two emerging areas of informational needs that
warrant greater attention include: (1) communication
about an HPV-related diagnosis and its impact on intim-
acy; and (2) support for decision making about clinical
trials. Although patients with HPV-related disease desire
more information regarding HPV and head and neck
cancer, communication and practical barriers (such as
physician time constraints, limited knowledge, and pa-
tient or physician discomfort in discussing sexual health)
reduce patient satisfaction with the information pro-
vided. With the increasing prevalence of HPV-related
HNCs, corresponding programs that address patient and
partner concerns regarding HPV-related issues are
greatly needed. Similarly, multiple challenges exist in the
enrollment of HNC patients to clinical trials, including
limited time for conveying large amounts of complex in-
formation, addressing informational needs of patients
and family members, and discussing patient preferences
and values. Findings derived from other cancer patient
populations suggest that novel web-based programs may
not only be an effective and cost-efficient approach for
delivering such information, but may also represent anacceptable and feasible format for communicating infor-
mation about multiple topics that can be tailored to
meet the unique needs of patients and family members.
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